IAOO 2015

Dr Nair talks to ecancertv at IAOO 2015 about the positioning of chemotherapy in the strategy against locally advanced oral cavity cancer. It is especially important in those patients for whom surgery isn't currently a good option, and may clear the path for surgical interventions later on.

Dr Subramanian talks to ecancertv at IAOO 2015 about his role in the Eurasian Federation of Oncology and the awareness-raising activities taking place as part of the World Head and Neck Cancer Day. Speeches by survivors and diagnostic services, among other things, will all contribute to this public health drive. He also explains some of the shortfalls and barriers to high quality standardised oncology care in Russia.

Prof Day talks to ecancertv at IAOO 2015 about the benefits of robotic surgery in oropharyngeal cancer. He explains how it is quicker and less invasive than conventional surgery which had involved incisions to the lip or jaw and meant less tumour visibility. He discusses the role of chemo and radiation therapy alongside surgery and ways to make diagnosis more precise in each patient to prevent people being under or over-treated. He also touches upon causes and methods of prevention such as the HPV vaccine. In addition to his role as Professor at the Medical University of South Carolina, Prof Day is also the president of the Head and Neck Cancer Alliance.

Dr Lai talks to ecancertv at IAOO 2015 about sentinel lymph node mapping and biopsy for early stage oral cavity cancer. He discusses the risks and therapies for patients with head and neck cancer, alongside important developments in care.

Prof Shaw talks to ecancertv at IAOO 2015 about the new toolkit he has been working on, in collaboration with Cancer Research UK. The oral cancer toolkit is aimed at doctors and dentist to make them aware of the early signs of oral cancer. The toolkit will be launched in November 2015, to coincide with the UK oral cancer awareness week.

Prof Shaw talks to ecancertv at IAOO 2015 about the Post-operative Adjuvant Treatment for HPV-positive Tumours (PATHOS) trial. This trial specifically looks at the role of surgery in HPV positive cases.

Prof Dedivitis talks to ecancertv at IAOO 2015 about the surgical management of parapharyngeal cancer, discussing some of the options available and some of the appropriate measures to help treat and diagnose.

Prof Shaw talks to ecancertv at IAOO 2015 about the international perspective on HPV prevention and how this is being fed into government policies.

Prof Shaw talks to ecancertv at IAOO 2015 about the exciting new developments in upper-jaw reconstructive surgery and patient care. He also discusses the collaboration with surgical teams and dental specialists in upper-jaw surgery.

Prof Ansarin talks to ecancertv at IAOO 2015 about dealing with the diagnosis and treatment of cancers of the head and neck (nasopharyngeal, oral cavity, pharynx, salivary glands, thyroid gland) and in particular the diagnosis and therapy of cancer of the larynx and hypopharynx with particular reference to the minimally invasive surgical technique laser or robot-assisted, research on predictors of response to therapy and those predictions.

Prof Chaturvedi talks to ecancertv at IAOO 2015 about the burden of head and neck cancer on the middle-aged portion of the population. In particular, he speaks of the lack of governmental awareness campaigns on the harmful impacts of alcohol, one of the main causes of mouth cancer.

Dr Kuriakose talks to ecancertv at IAOO 2015 about oral cavity cancer and the importance of developing a guideline for when and how to treat patients whose diseases is in the late stage. He also discusses the affect of tobacco and alcohol on the occurrence of oral cavity cancer.

Prof Gross talks to ecancertv at IAOO 2015 about some advantages, complications and pitfalls surrounding transoral robotic surgery.

Prof Shaw talks to ecancertv at IAOO 2015 about his work on pre-malignant lesions and prevention of head and neck, and oral cancer, as well as chemo-prevention trials and biomarkers.

Dr Curado talks to ecancertv at IAOO 2015 about epidemiological changes which take place to cause oral cancer. She explains how tobacco, unprotected sex (HPV) and alcohol are all risk factors that the public need to be made more aware of, especially since this type of cancer is not a priority in government screening programmes. She highlights the need for patients to be aware of oral cancer and to get their doctor or dentist to check, since it is ordinarily not found until in its late stage.

Prof Brekel talks to ecancertv at IAOO 2015 about management and assessment of head and neck cancer and the developments in treatment options, including imaging and PET-CT.

Prof Patel talks to ecancertv at IAOO 2015 about the available treatments to manage the head and neck in locally advanced oral cancers. He also discusses prominence of throat and neck cancers in India, discussing some of the systems and practises surrounding their treatments.

Prof Kowalski talks to ecancertv at IAOO 2015 about the highlights from the meeting. He discusses the developments in prevention of head and neck cancer, how to detect oral cancers and the sophisticated modifications in treatments.

Prof Shah talks to ecancertv at IAOO 2015 about successes and realities in non-surgical head and neck cancer treatment. In particular, he discusses quality of life matters and how these should better influence treatment decisions. In addition, he highlights the importance of the international day for head and neck cancer awareness, which takes place on the 27th of July every year.

Dr Shannon talks to ecancertv at IAOO 2015 about the application of 3D printing for creating custom prosthetics for the head using multiple materials such as titanium.

Dr Ridge talks to ecancertv at IAOO 2015 about the role of induction chemotherapy and concurrent chemoradiation in treating unresectable head and neck cancer. He also discusses his therapy and treatment recommendations for doctors.

Dr D'Souza talks to ecancertv at IAOO 2015 about the role of HPV in head and neck cancer and how it varies across different countries in the world. The studies consolidated tumour samples, risk factor survey information and survival information in order to centrally test for P16 and HPV16 DNA, two biomarkers that show if a tumour is HPV related.

Prof Corry talks to ecancertv at IAOO 2015 about chemoradiation in head and neck cancer and the difference in survival outcomes from big centres compared to small ones. She also notes the need for investigator-driven trials which look into aspects of treatment that are not a pharmaceutical company's top priority.

Prof Özsahin talks to ecancertv at IAOO 2015 about his work looking at chemoradiotherapy versus radiotherapy in head and neck cancer.

Prof Warnakulasuriya talks to ecancertv at IAOO 2015 about the epidemiology of risk factors for cancer, with particular reference to the South Asia and Asia Pacific region and the penchant for betel-quid and Areca-nut chewing.

Prof de Castro talks to ecancertv at IAOO 2015 about head and neck squamous cell carcinoma and the impact of the microenvironment on immune tolerance with particular reference to PD-1.

Dr Maluf talks to ecancertv at IAOO 2015 about head and neck cancer and it's greater occurrence in developing countries such as Brazil. He explains how alcohol and tobacco are key factors and argues for increased education of the public of the dangers. He also champions the benefits of immunological treatment approaches.

Prof Kraus talks to ecancertv at IAOO 2015 about his discussion on quality of life for patients with head and neck cancer. He discusses the developments in endoscopy, reconstructive surgery and patient care.

Prof Miles talks to ecancertv at IAOO 2015 about a virtual surgery programme that allows surgeons to practice and plan before real reconstructive surgery.

Prof Kraus talks to ecancertv at IAOO 2015 about the work of the American Head and Neck society (AHNS) and their advocacy for patients with head and neck cancer. He also discusses the emergence of Human papillomavirus (HPV).

Prof Kraus talks to ecancertv at IAOO 2015 about the emergence of HPV, and the changes and developments he has seen throughout his career in head and neck surgery. He also discusses the counselling that he offers patients who suffer from head and neck cancer.

Prof de Abreu Alves talks to ecancertv at IAOO 2015 about the merits of the congress and quality of life challenges in need of consideration in head and neck cancer.